The immunology of epilepsy
Nature Medicine
March 29, 2010
A signaling pathway known for its role in immune defense responses is also involved in epilepsy, according to a report in this week's Nature Medicine. The discovery could potentially be useful in the development of new anti-convulsant agents.
Brain inflammation is a major factor in epilepsy, but the impact of specific inflammatory molecules on the disease is not fully understood. Using several models of epilepsy in mice, Annamaria Vezzani and her colleagues discovered that release of a molecule called HMGB1 from neurons and glia and its interaction with a receptor key for the immune response against pathogens ― TLR4 ― promoted seizures.
The researchers also found that blocking the action of HMGB1 and TLR4 decreased seizure frequency. Mice lacking TLR4 were also resistant to manipulations known to induce seizures. Last, increased levels of HMGB1 and TLR4 in epileptogenic tissue from patients pointed to the potential human relevance of this mechanism, which could be targeted to develop new anticonvulsant agents.
doi: 10.1038/nm.2127
Research highlights
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports
-
Jun 16
Microbiology: DNA analysis indicates origins of the Black DeathNature